Brief: Crystal Genomics receives U.S. patent

CG Invites

13/09/2017 03:17

Sept 13 (Reuters) - Crystal Genomics Inc  083790.KQ  : 
 
    * Says it received U.S. patent on Sep. 13, for 
2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, 
and pharmaceutical composition including same 
 
    Source text in Korean: https://goo.gl/j1wMbi 
    Further company coverage:  083790.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))